Viking plans to explore monthly dosing for ... for weight loss in the ongoing VENTURE trial for oral VK2735. Brian Lian ...

"We are excited to enter into this agreement with one of the world's leading CDMOs in the peptide space," said Brian Lian, Ph.D., chief executive officer of Viking Therapeutics. "We have a long ...

“The first quarter of 2024 was an exceptional period for Viking,” stated Brian Lian, Ph.D., president and CEO of Viking. “During the quarter, the company reported positive top-line results ...

The data released by Viking showed that adults taking the highest ... effective maintenance of weight control," said Viking CEO Brian Lian, Ph.D., in a statement. Profit and prosper with the ...

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian ...